<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34705518</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1946-6242</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>617</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>Science translational medicine</Title><ISOAbbreviation>Sci Transl Med</ISOAbbreviation></Journal><ArticleTitle>Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G<sub>4</sub>C<sub>2</sub>) repeat expansion in vitro and in vivo ALS models.</ArticleTitle><Pagination><StartPage>eabd5991</StartPage><MedlinePgn>eabd5991</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1126/scitranslmed.abd5991</ELocationID><Abstract><AbstractText>The most common cause of amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD) is an expanded G<sub>4</sub>C<sub>2</sub> RNA repeat [r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup>] in chromosome 9 open reading frame 72 (<i>C9orf72</i>), which elicits pathology through several mechanisms. Here, we developed and characterized a small molecule for targeted degradation of r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup>. The compound was able to selectively bind r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup>&#x2019;s structure and to assemble an endogenous nuclease onto the target, provoking removal of the transcript by native RNA quality control mechanisms. In c9ALS patient&#x2013;derived spinal neurons, the compound selectively degraded the mutant <i>C9orf72</i> allele with limited off-targets and reduced quantities of toxic dipeptide repeat proteins (DPRs) translated from r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup>. In vivo work in a rodent model showed that abundance of both the mutant allele harboring the repeat expansion and DPRs were selectively reduced by this compound. These results demonstrate that targeted small-molecule degradation of r(G<sub>4</sub>C<sub>2</sub>)<sup>exp</sup> is a strategy for mitigating c9ALS/FTD-associated pathologies and studying disease-associated pathways in preclinical models.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bush</LastName><ForeName>Jessica A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0001-9474-1608</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aikawa</LastName><ForeName>Haruo</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-2536-900X</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuerst</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ursu</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Samantha M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0003-3353-6939</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benhamou</LastName><ForeName>Raphael I</ForeName><Initials>RI</Initials><Identifier Source="ORCID">0000-0003-1743-0886</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jonathan L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-7907-9732</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Tanya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0323-8017</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner-Griffin</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4718-6909</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Meter</LastName><ForeName>Montina J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-9313-2162</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Yuquan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0793-7747</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olafson</LastName><ForeName>Hailey</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>Kendra K</ForeName><Initials>KK</Initials><Identifier Source="ORCID">0000-0002-1657-5998</Identifier><AffiliationInfo><Affiliation>Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Childs-Disney</LastName><ForeName>Jessica L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendron</LastName><ForeName>Tania F</ForeName><Initials>TF</Initials><Identifier Source="ORCID">0000-0002-7335-2627</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9900-4313</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coyne</LastName><ForeName>Alyssa N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0002-3658-5325</Identifier><AffiliationInfo><Affiliation>Robert Packard Center for ALS Research, Johns Hopkins University School of Medicine, 855 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Eric T</ForeName><Initials>ET</Initials><Identifier Source="ORCID">0000-0003-2655-5525</Identifier><AffiliationInfo><Affiliation>Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, FL 32610, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yildirim</LastName><ForeName>Ilyas</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Florida Atlantic University, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Kye Won</ForeName><Initials>KW</Initials><Identifier Source="ORCID">0000-0002-5718-0685</Identifier><AffiliationInfo><Affiliation>Department of Chemistry and Biochemistry, Florida Atlantic University, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrucelli</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2959-129X</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothstein</LastName><ForeName>Jeffrey D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0003-2001-8470</Identifier><AffiliationInfo><Affiliation>Robert Packard Center for ALS Research, Johns Hopkins University School of Medicine, 855 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Disney</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0001-8486-1796</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 NS099114</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS116846</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS097273</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP1 NS096898</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD021550</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Transl Med</MedlineTA><NlmUniqueID>101505086</NlmUniqueID><ISSNLinking>1946-6234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.-</RegistryNumber><NameOfSubstance UI="D012260">Ribonucleases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="AssociatedDataset"><RefSource>Nat Rev Drug Discov. 2021 Dec;20(12):897</RefSource><PMID Version="1">34732854</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012260" MajorTopicYN="N">Ribonucleases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing interests:</b> M.D.D. is a founder of Expansion Therapeutics. M.D.D. is a consultant for Expansion Therapeutics, and E.T.W. was a consultant for Expansion Therapeutics during the course of these studies. A patent disclosure has been filed on aspects of this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>27</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34705518</ArticleId><ArticleId IdType="mid">NIHMS1838863</ArticleId><ArticleId IdType="pmc">PMC9533739</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abd5991</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R, Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245&#x2013;256 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Holtta-Vuori M, Ikonen E, Sulkava R, Benatar M, Wuu J, Chio A, Restagno G, Borghero G, Sabatelli M; The ITALSGEN Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ, A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257&#x2013;268 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S, Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am. J. Hum. Genet 92, 345&#x2013;353 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591848</ArticleId><ArticleId IdType="pubmed">23434116</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NA, Bauer PO, Serrano G, Beach TG, Josephs KA, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Boylan KB, Petrucelli L, Dickson DW, Rademakers R, Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): A cross-sectional cohort study. Lancet Neurol. 12, 978&#x2013;988 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879782</ArticleId><ArticleId IdType="pubmed">24011653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul III JW, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77, 639&#x2013;646 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M, Van Broeckhoven C, Kremmer E, Kretzschmar HA, Haass C, Edbauer D, Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126, 881&#x2013;893 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D, The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339, 1335&#x2013;1338 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC, Ranum LP, RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A 110, E4968&#x2013;E4977 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, Daughrity L, Dunmore JH, Castanedes-Casey M, Chew J, Cosio DM, van Blitterswijk M, Lee WC, Rademakers R, Boylan KB, Dickson DW, Petrucelli L, Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126, 829&#x2013;844 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A, Stankowski JN, Disney MD, Rothstein JD, Dickson DW, Fryer JD, Zhang YJ, Petrucelli L, Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol. Neurodegener 14, 9 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling SC, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg SR, Yeo GW, Fu XD, Bennett CF, Cleveland DW, Ravits J, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl. Acad. Sci. U.S.A 110, E4530&#x2013;E4539 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZF, Ursu A, Childs-Disney JL, Guertler R, Yang WY, Bernat V, Rzuczek SG, Fuerst R, Zhang YJ, Gendron TF, Yildirim I, Dwyer BG, Rice JE, Petrucelli L, Disney MD, The hairpin form of r(G4C2)exp in c9ALS/FTD is repeat-associated non-ATG translated and a target for bioactive small molecules. Cell Chem. Biol 26, 179&#x2013;190.e112 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6386614</ArticleId><ArticleId IdType="pubmed">30503283</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z, Zhang Y, Gendron TF, Bauer PO, Chew J, Yang WY, Fostvedt E, Jansen-West K, Belzil VV, Desaro P, Johnston A, Overstreet K, Oh SY, Todd PK, Berry JD, Cudkowicz ME, Boeve BF, Dickson D, Floeter MK, Traynor BJ, Morelli C, Ratti A, Silani V, Rademakers R, Brown RH, Rothstein JD, Boylan KB, Petrucelli L, Disney MD, Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron 83, 1043&#x2013;1050 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232217</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Costales MG, Aikawa H, Li Y, Childs-Disney JL, Abegg D, Hoch DG, Velagapudi SP, Nakai Y, Khan T, Wang KW, Yildirim I, Adibekian A, Wang ET, Disney MD, Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer. Proc. Natl. Acad. Sci. U.S.A 117, 2406&#x2013;2411 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7007575</ArticleId><ArticleId IdType="pubmed">31964809</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K, Zamiri B, Stanley SY, Macgregor RB Jr., Pearson CE, The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J. Biol. Chem 288, 9860&#x2013;9866 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Disney MD, Winkelsas AM, Velagapudi SP, Southern M, Fallahi M, Childs-Disney JL, Inforna 2.0: A platform for the sequence-based design of small molecules targeting structured RNAs. ACS Chem. Biol 11, 1720&#x2013;1728 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4912454</ArticleId><ArticleId IdType="pubmed">27097021</ArticleId></ArticleIdList></Reference><Reference><Citation>Velagapudi SP, Gallo SM, Disney MD, Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat. Chem. Biol 10, 291&#x2013;297 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3962094</ArticleId><ArticleId IdType="pubmed">24509821</ArticleId></ArticleIdList></Reference><Reference><Citation>Disney MD, Targeting RNA with small molecules to capture opportunities at the Intersection of chemistry, biology, and medicine. J. Am. Chem. Soc 141, 6776&#x2013;6790 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6541398</ArticleId><ArticleId IdType="pubmed">30896935</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan L, Disney MD, Covalent small-molecule-RNA complex formation enables cellular profiling of small-molecule-RNA interactions. Angew. Chem. Int. Ed. Engl 52, 10010&#x2013;10013 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3876275</ArticleId><ArticleId IdType="pubmed">23913698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzuczek SG, Colgan LA, Nakai Y, Cameron MD, Furling D, Yasuda R, Disney MD, Precise small-molecule recognition of a toxic CUG RNA repeat expansion. Nat. Chem. Biol 13, 188&#x2013;193 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5290590</ArticleId><ArticleId IdType="pubmed">27941760</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs-Disney JL, Tran T, Vummidi BR, Velagapudi SP, Haniff HS, Matsumoto Y, Crynen G, Southern MR, Biswas A, Wang Z-F, Tellinghuisen TL, Disney MD, A massively parallel selection of small molecule-RNA motif binding partners informs design of an antiviral from sequence. Chem 4, 2384&#x2013;2404 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6358276</ArticleId><ArticleId IdType="pubmed">30719503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Park H-J, Zhang J, Junnb E, Andrews RJ, Velagapudi SP, Abegg D, Vishnu K, Costales MG, Childs-Disney JL, Adibekian A, Moss WN, Mouradian MM, Disney MD, Translation of the intrinsically disordered protein &#x3b1;-synuclein is inhibited by a small molecule targeting its structured mRNA. Proc. Natl. Acad. Sci. U.S.A 117, 1457&#x2013;1467 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6983430</ArticleId><ArticleId IdType="pubmed">31900363</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D, Chun S, Sun S, Ling SC, Myers B, Engelhardt J, Katz M, Baughn M, Platoshyn O, Marsala M, Watt A, Heyser CJ, Ard MC, De Muynck L, Daughrity LM, Swing DA, Tessarollo L, Jung CJ, Delpoux A, Utzschneider DT, Hedrick SM, de Jong PJ, Edbauer D, Van Damme P, Petrucelli L, Shaw CE, Bennett CF, Da Cruz S, Ravits J, Rigo F, Cleveland DW, Lagier-Tourenne C, Gain of toxicity from ALS/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron 90, 535&#x2013;550 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD, RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415&#x2013;428 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang YJ, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O&#x2019;Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, Tabassian LJ, Lee CW, Yue M, Tong J, Song Y, Castanedes-Casey M, Rousseau L, Phillips V, Dickson DW, Rademakers R, Fryer JD, Rush BK, Pedraza O, Caputo AM, Desaro P, Palmucci C, Robertson A, Heckman MG, Diehl NN, Wiggs E, Tierney M, Braun L, Farren J, Lacomis D, Ladha S, Fournier CN, McCluskey LF, Elman LB, Toledo JB, McBride JD, Tiloca C, Morelli C, Poletti B, Solca F, Prelle A, Wuu J, Jockel-Balsarotti J, Rigo F, Ambrose C, Datta A, Yang W, Raitcheva D, Antognetti G, McCampbell A, Van Swieten JC, Miller BL, Boxer AL, Brown RH, Bowser R, Miller TM, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Traynor BJ, Disney MD, Benatar M, Silani V, Glass JD, Floeter MK, Rothstein JD, Boylan KB, Petrucelli L, Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Sci. Transl. Med 9, eaai7866 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576451</ArticleId><ArticleId IdType="pubmed">28356511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sznajder &#x141;J, Thomas JD, Carrell EM, Reid T, McFarland KN, Cleary JD, Oliveira R, Nutter CA, Bhatt K, Sobczak K, Ashizawa T, Thornton CA, Ranum LPW, Swanson MS, Intron retention induced by microsatellite expansions as a disease biomarker. Proc. Natl. Acad. Sci. U.S.A 115, 4234&#x2013;4239 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910826</ArticleId><ArticleId IdType="pubmed">29610297</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannes G, Carter MS, Eisen MB, Brown PO, Sarnow P, Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc. Natl. Acad. Sci. U.S.A 96, 13118&#x2013;13123 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23910</ArticleId><ArticleId IdType="pubmed">10557283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong Q, Schummer M, Hood L, Morris DR, Messenger RNA translation state: The second dimension of high-throughput expression screening. Proc. Natl. Acad. Sci. U.S.A 96, 10632&#x2013;10636 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17934</ArticleId><ArticleId IdType="pubmed">10485877</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada SB, Gendron TF, Niccoli T, Genuth NR, Grosely R, Shi Y, Glaria I, Kramer NJ, Nakayama L, Fang S, Dinger TJI, Thoeng A, Rocha G, Barna M, Puglisi JD, Partridge L, Ichida JK, Isaacs AM, Petrucelli L, Gitler AD, RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat. Neurosci 22, 1383&#x2013;1388 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WY, He F, Strack RL, Oh SY, Frazer M, Jaffrey SR, Todd PK, Disney MD, Small molecule recognition and tools to study modulation of r(CGG)exp in fragile X-associated tremor ataxia syndrome. ACS Chem. Biol 11, 2456&#x2013;2465 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549791</ArticleId><ArticleId IdType="pubmed">27276216</ArticleId></ArticleIdList></Reference><Reference><Citation>Costales MG, Matsumoto Y, Velagapudi SP, Disney MD, Small molecule targeted recruitment of a nuclease to RNA. J. Am. Chem. Soc 140, 6741&#x2013;6744 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6100793</ArticleId><ArticleId IdType="pubmed">29792692</ArticleId></ArticleIdList></Reference><Reference><Citation>Costales MG, Suresh B, Vishnu K, Disney MD, Targeted degradation of a hypoxia-associated non-coding RNA enhances the selectivity of a small molecule interacting with RNA. Cell Chem. Biol 26, 1180&#x2013;1186.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697612</ArticleId><ArticleId IdType="pubmed">31130520</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur CS, Jha BK, Dong B, Das Gupta J, Silverman KM, Mao H, Sawai H, Nakamura AO, Banerjee AK, Gudkov A, Silverman RH, Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc. Natl. Acad. Sci. U.S.A 104, 9585&#x2013;9590 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1877983</ArticleId><ArticleId IdType="pubmed">17535916</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Donovan J, Rath S, Whitney G, Chitrakar A, Korennykh A, Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science 343, 1244&#x2013;1248 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731867</ArticleId><ArticleId IdType="pubmed">24578532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P, Muhammad AKMG, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, Gendron T, Petrucelli L, Baughn M, Ravits J, Harms MB, Rigo F, Bennett CF, Otis TS, Svendsen CN, Baloh RH, Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci. Transl. Med 5, 208ra149 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Lu Y, Lopez-Gonzalez R, Kim NC, Almeida S, Lee KH, Badders N, Valentine M, Miller BL, Wong PC, Petrucelli L, Kim HJ, Gao FB, Taylor JP, GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525, 129&#x2013;133 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Zaepfel BL, Hayes L, Fitchman B, Salzberg Y, Luo EC, Bowen K, Trost H, Aigner S, Rigo F, Yeo GW, Harel A, Svendsen CN, Sareen D, Rothstein JD, G4C2 repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron 107, 1124&#x2013;1140.e11 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Taylor JP, Lost in transportation: Nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases. Neuron 96, 285&#x2013;297 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pattamatta A, Zu T, Reid T, Bardhi O, Borchelt DR, Yachnis AT, Ranum LPW, C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron 90, 521&#x2013;534 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Frick P, Neumann M, The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol. 127, 347&#x2013;357 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24356984</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary JD, Ranum LP, Repeat associated non-ATG (RAN) translation: New starts in microsatellite expansion disorders. Curr. Opin. Genet. Dev 26, 6&#x2013;15 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237677</ArticleId><ArticleId IdType="pubmed">24852074</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverria GV, Cooper TA, RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity. Brain Res. 1462, 100&#x2013;111 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372679</ArticleId><ArticleId IdType="pubmed">22405728</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohan A, Goodwin M, Swanson MS, RNA-protein interactions in unstable microsatellite diseases. Brain Res. 1584, 3&#x2013;14 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4174988</ArticleId><ArticleId IdType="pubmed">24709120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalavade R, Griesche N, Ryan DP, Hildebrand S, Krauss S, Mechanisms of RNA-induced toxicity in CAG repeat disorders. Cell Death Dis. 4, e752 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763438</ArticleId><ArticleId IdType="pubmed">23907466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranum LPW, Cooper TA, RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci 29, 259&#x2013;277 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16776586</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson ML, Zamecnik PC, Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. U.S.A 75, 285&#x2013;288 (1978).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC411231</ArticleId><ArticleId IdType="pubmed">75546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, Dirksen RT, Thornton CA, Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325, 336&#x2013;339 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4109973</ArticleId><ArticleId IdType="pubmed">19608921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K, Wu J, Bezprozvanny I, Corey DR, Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat. Biotechnol 27, 478&#x2013;484 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2765218</ArticleId><ArticleId IdType="pubmed">19412185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingwell K, Double setback for ASO trials in Huntington disease. Nat. Rev. Drug Discov 20, 412&#x2013;413 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34012000</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorova O, Jagdmann GE Jr., Adams RL, Yuan L, Van Zandt MC, Pyle AM, Small molecules that target group II introns are potent antifungal agents. Nat. Chem. Biol 14, 1073&#x2013;1078 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6239893</ArticleId><ArticleId IdType="pubmed">30323219</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JL, Zhang P, Abe M, Aikawa H, Zhang L, Frank AJ, Zembryski T, Hubbs C, Park H, Withka J, Steppan C, Rogers L, Cabral S, Pettersson M, Wager TT, Fountain MA, Rumbaugh G, Childs-Disney JL, Disney MD, Design, optimization, and study of small molecules that target Tau pre-mRNA and affect splicing. J. Am. Chem. Soc 142, 8706&#x2013;8727 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357857</ArticleId><ArticleId IdType="pubmed">32364710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratni H, Ebeling M, Baird J, Bendels S, Bylund J, Chen KS, Denk N, Feng Z, Green L, Guerard M, Jablonski P, Jacobsen B, Khwaja O, Kletzl H, Ko C-P, Kustermann S, Marquet A, Metzger F, Mueller B, Naryshkin NA, Paushkin SV, Pinard E, Poirier A, Reutlinger M, Weetall M, Zeller A, Zhao X, Mueller L, Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA). J. Med. Chem 61, 6501&#x2013;6517 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30044619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B, Reddy K, Macgregor RB Jr., Pearson CE, TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins. J. Biol. Chem 289, 4653&#x2013;4659 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931028</ArticleId><ArticleId IdType="pubmed">24371143</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R, Balendra R, Moens TG, Preza E, Wilson KM, Heslegrave A, Woodling NS, Niccoli T, Gilbert-Jaramillo J, Abdelkarim S, Clayton EL, Clarke M, Konrad MT, Nicoll AJ, Mitchell JS, Calvo A, Chio A, Houlden H, Polke JM, Ismail MA, Stephens CE, Vo T, Farahat AA, Wilson WD, Boykin DW, Zetterberg H, Partridge L, Wray S, Parkinson G, Neidle S, Patani R, Fratta P, Isaacs AM, G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Mol. Med 10, 22&#x2013;31 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursu A, Wang KW, Bush JA, Choudhary S, Chen JL, Baisden JT, Zhang YJ, Gendron TF, Petrucelli L, Yildirim I, Disney MD, Structural features of small molecules targeting the RNA repeat expansion that causes genetically defined ALS/FTD. ACS Chem. Biol 15, 3112&#x2013;3123 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7788565</ArticleId><ArticleId IdType="pubmed">33196168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, An Y, Chen ZS, Koon AC, Lau KF, Ngo JCK, Chan HYE, A peptidylic inhibitor for neutralizing r(GGGGCC)exp-associated neurodegeneration in C9ALS-FTD. Mol. Ther. Nucleic Acids 16, 172&#x2013;185 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6424097</ArticleId><ArticleId IdType="pubmed">30889483</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelbello AJ, Rzuczek SG, McKee KK, Chen JL, Olafson H, Cameron MD, Moss WN, Wang ET, Disney MD, Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model. Proc. Natl. Acad. Sci. U.S.A 116, 7799&#x2013;7804 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6475439</ArticleId><ArticleId IdType="pubmed">30926669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobczak K, de Mezer M, Michlewski G, Krol J, Krzyzosiak WJ, RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res. 31, 5469&#x2013;5482 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC206466</ArticleId><ArticleId IdType="pubmed">14500809</ArticleId></ArticleIdList></Reference><Reference><Citation>Michlewski G, Krzyzosiak WJ, Molecular architecture of CAG repeats in human disease related transcripts. J. Mol. Biol 340, 665&#x2013;679 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15223312</ArticleId></ArticleIdList></Reference><Reference><Citation>Busan S, Weeks KM, Role of context in RNA structure: Flanking sequences reconfigure CAG motif folding in huntingtin exon 1 transcripts. Biochemistry 52, 8219&#x2013;8225 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4890576</ArticleId><ArticleId IdType="pubmed">24199621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews DH, Disney MD, Childs JL, Schroeder SJ, Zuker M, Turner DH, Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc. Natl. Acad. Sci. U.S.A 101, 7287&#x2013;7292 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC409911</ArticleId><ArticleId IdType="pubmed">15123812</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathews DH, Sabina J, Zuker M, Turner DH, Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol 288, 911&#x2013;940 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10329189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang TL, Shaka AJ, Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson 112, 275&#x2013;279 (1995).</Citation></Reference><Reference><Citation>Grzesiek S, Bax A, The importance of not saturating water in protein NMR. Application to sensitivity enhancement and NOE measurements. J. Am. Chem. Soc 115, 12593&#x2013;12594 (1993).</Citation></Reference><Reference><Citation>Piotto M, Saudek V, Sklen&#xe1;&#x159; V, Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 2, 661&#x2013;665 (1992).</Citation><ArticleIdList><ArticleId IdType="pubmed">1490109</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddard TD, Kneller DG (University of California, San Francisco, 2004).</Citation></Reference><Reference><Citation>Angelbello AJ, Disney MD, Bleomycin can cleave an oncogenic noncoding RNA. Chembiochem 19, 43&#x2013;47 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5810124</ArticleId><ArticleId IdType="pubmed">29084369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WY, Wilson HD, Velagapudi SP, Disney MD, Inhibition of non-ATG translational events in cells via covalent small molecules targeting RNA. J. Am. Chem. Soc 137, 5336&#x2013;5345 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856029</ArticleId><ArticleId IdType="pubmed">25825793</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs-Disney JL, Yildirim I, Park H, Lohman JR, Guan L, Tran T, Sarkar P, Schatz GC, Disney MD, Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity. ACS Chem. Biol 9, 538&#x2013;550 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944380</ArticleId><ArticleId IdType="pubmed">24341895</ArticleId></ArticleIdList></Reference><Reference><Citation>Childs-Disney JL, Stepniak-Konieczna E, Tuan T, Yildirim I, Park H, Chen CZ, Hoskins J, Southall N, Marugan JJ, Patnaik S, Zheng W, Austin CP, Schatz GC, Sobczak K, Thornton CA, Disney MD, Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules. Nat. Commun 4, 2044 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710115</ArticleId><ArticleId IdType="pubmed">23806903</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA, Development and testing of a general amber force field. J. Comput. Chem 25, 1157&#x2013;1174 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15116359</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayly CI, Cieplak P, Cornell WD, Kollman PA, A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model. J. Phys. Chem 97, 10269&#x2013;10280 (1993).</Citation></Reference><Reference><Citation>Cornell WD, Cieplak P, Bayly CI, Kollman PA, Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation. J. Am. Chem. Soc 115, 9620&#x2013;9631 (1993).</Citation></Reference><Reference><Citation>Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Petersson GA, Nakatsuji H, Li X, Caricato M, Marenich A, Bloino J, Janesko BG, Gomperts R, Mennucci B, Hratchian HP, Ortiz JV, Izmaylov AF, Sonnenberg JL, Williams-Young D, Ding F, Lipparini F, Egidi F, Goings J, Peng B, Petrone A, Henderson T, Ranasinghe D, Zakrzewski VG, Gao J, Rega N, Zheng G, Liang W, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Throssell K, J. Montgomery JA, Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Keith T, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Millam JM, Klene M, Adamo C, Cammi R, Ochterski JW, Martin RL, Morokuma K, Farkas O, Foresman JB, Fox DJ, Gaussian 09 (Gaussian Inc., 2016).</Citation></Reference><Reference><Citation>Sangster MJL, Atwood RM, Interionic potentials for alkali halides. II. Completely crystal independent specification of Born-Mayer potentials. J. Phys. C Solid State Phys 11, 1541&#x2013;1555 (1978).</Citation></Reference><Reference><Citation>Cheatham III TE, Miller JL, Fox T, Darden TA, Kollman PA, Molecular dynamics simulations on solvated biomolecular systems: The particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. J. Am. Chem. Soc 117, 4193&#x2013;4194 (1995).</Citation></Reference><Reference><Citation>Bedn&#xe1;&#x159;ov&#xe1; E, Hybelbauerov&#xe1; S, Jind&#x159;ich J, Optimized methods for preparation of 6I-(&#x3c9;-sulfanyl-alkylene-sulfanyl)-&#x3b2;-cyclodextrin derivatives. Beilstein J. Org. Chem 12, 349&#x2013;352 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4778511</ArticleId><ArticleId IdType="pubmed">26977195</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan M, Bujotzek A, Abendroth F, Wellner A, Gust R, Seitz O, Weber M, Haag R, Conformational analysis of bivalent estrogen receptor ligands: From intramolecular to intermolecular binding. Chembiochem 12, 2587&#x2013;2598 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22025425</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Yang J, Development of a folate receptor (FR)-targeted indenoisoquinoline using a pH-sensitive N-ethoxybenzylimidazole (NEBI) bifunctional cross-linker. Bioconjug. Chem 25, 873&#x2013;878 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4032194</ArticleId><ArticleId IdType="pubmed">24758386</ArticleId></ArticleIdList></Reference><Reference><Citation>Dra&#x10d;&#xed;nsk&#xfd; M, Sejbal J, Rygerov&#xe1; B, Stiborov&#xe1; M, An efficient modification of ellipticine synthesis and preparation of 13-hydroxyellipticine. Tetrahedron Lett. 48, 6893&#x2013;6895 (2007).</Citation></Reference><Reference><Citation>Mandl CP, K&#xf6;nig B, Synthesis of mono protected 1,10-diaza-18-crown-6. Synth. Commun 34, 3573&#x2013;3578 (2004).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>